Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study

By Mitachi Yashushi   Sakata Yuh   Ohtsu Atsushi   Hyodo Ichinosuke   Katsu Kenichi   Sairenji Motonori   Saitoh Soh   Suwa Toshikazu   Sato Toshinobu   Miyata Yoshinori  

Gastric Cancer, Vol. 5, Iss. 3, 2002-09 ,pp. : 160-167

Springer Publishing Company

Access to resources Recommend Favorite

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

By Chitapanarux I.   Tonusin A.   Sukthomya V.   Charuchinda C.   Pukanhapan N.   Lorvidhaya V.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 402-407

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Taxol as a Radiation Sensitizer with Cisplatin in Advanced Cervical Cancer

By Chen M.D.   Paley P.J.   Potish R.A.   Twiggs L.B.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 131-136

Elsevier

Access to resources Recommend Favorite

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

By Rein D.T.   Kurbacher C.M.   Breidenbach M.   Schöndorf T.   Schmidt T.   König E.       Mallmann P.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 98-103

Academic Press

Access to resources Recommend Favorite

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

By Lhomme C.   Vermorken J.B.   Mickiewicz E.   Chevalier B.   Alvarez A.   Mendiola C.   Pawinski A.   Lentz M.A.   Pecorelli S.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 194-199

Elsevier

Access to resources Recommend Favorite